Abstract
It remains elusive what factors induce growth without growth hormone (GWGH) in children after neurosurgery of brain tumors. Growth velocity and endocrinological data were compared between the patients with and without GWGH. We experienced three patients with GWGH (median, 12 years; 2 germinoma and 1 craniopharyngioma; three females; group 1) and 11 patients without (12 years; 8 craniopharyngioma, 2 germinoma and 1 medulloblastoma; 7 males; group 2) after neurosurgery. All patients in group 2 received GH replacement therapy. Growth velocity and endocrinological data were compared. Median height velocity was normal in group 1 (5.5 cm/year), but low in group 2 (2.2 cm/year), which improved after GH replacement therapy (7.0 cm/year). Median serum insulin level was increased in group 1 (87.0 μU/ml, P < 0.05) compared with normal level in group 2 (10.0 μU/ml). Despite hyperinsulinemia, serum glucose level was normal in group 1. Three of 5 with hyperinsulinemia and 2 of 9 without were obese or overweight, but the difference was not significant. Current body mass index and serum levels of IGF-1, IGFBP-3, leptin, and prolactin were similar between groups. Serum estradiol was prepuberty level in group 1. Hyperinsulinemia may induce GWGH in children with brain tumors after neurosurgery.
This is a preview of subscription content, log in via an institution to check access.
References
H. Bucher, J. Zapf, T. Torresani, A. Prader, E.R. Froesch, R. Illig, Insulin-like growth factors I, II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N. Engl. J. Med. 309, 1142–1146 (1983)
G. Pinto, L. Bussieres, C. Recasens, J.C. Souberbielle, M. Zerah, R. Brauner, Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm. Res. 53, 163–169 (2000)
M. Pavlou, A. Tsatsoulis, Z. Efstathiadou, S. Bitsis, Z.L. Papadopoulou, A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the “growth without GH” syndrome. Growth Horm. Igf Res. 11, 225–230 (2001)
S. Srinivasan, M.J. Waters, J.E. Rowland, R.C. Baxter, C.F. Verge, Hyperinsulinism and overgrowth without obesity. Arch. Dis. Child. 88, 332–334 (2003)
S. Srinivasan, G.D. Ogle, S.P. Garnett, J.N. Briody, J.W. Lee, C.T. Cowell, Features of the metabolic syndrome after childhood craniopharyngioma. J. Clin. Endocrinol. Metab. 89, 81–86 (2004)
E. Di Battista, A. Naselli, S. Queirolo, F. Gallarotti, M.L. Garre, C. Milanaccio et al., Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study. J. Pediatr. Endocrinol. Metab. 19(Suppl 1), 431–437 (2006)
K. Araki, M. Koga, T. Okada, T. Kurashige, K. Naruse, M. Hiroi, A boy with normal growth in spite of growth hormone deficiency after resection of a suprasellar teratoma. Endocr. J. 47(Suppl), S101–S104 (2000)
M.E. Geffner, The growth without growth hormone syndrome. Endocrinol. Metab. Clin. North Am. 25, 649–663 (1996)
N. Kato, K. Sato, H. Takimoto, N. Sudo, BMI for age references for Japanese children—based on the 2000 growth survey. Asia Pac. J. Public Health 20(Suppl), 118–127 (2008)
A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)
Acknowledgment
The authors would like to thank Tsuguhisa Toma for his great contribution to the analysis of the data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwayama, H., Kamijo, T. & Ueda, N. Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors. Endocrine 40, 130–133 (2011). https://doi.org/10.1007/s12020-011-9493-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9493-y